View the Latest: Low Income
Filter
-
-
Visualizing Health Policy: Medicaid Expansion Under the Affordable Care Act
OtherThe March 2013 Visualizing Health Policy infographic looks at how expanding Medicaid under the Affordable Care Act will impact low-income and uninsured people, and how these groups will be affected in states that do not expand the program.
-
An Overview of Medicaid Incentives for the Prevention of Chronic Diseases (MIPCD) Grants
Issue BriefThis brief provides an overview of the Medicaid Incentives for the Prevention of Chronic Diseases (MIPCD) grants and highlights key findings from the interim evaluation of the program. The brief also places these grants in context of pre-Affordable Care Act (ACA) Medicaid beneficiary incentive programs and proposed programs of states that are incorporating healthy behavior incentives into Medicaid expansion waivers.
-
Medicare Part D in Its Ninth Year: The 2014 Marketplace and Key Trends, 2006-2014
ReportThis report presents findings from an analysis of the Medicare Part D marketplace in 2014 and changes in features of the drug benefit offered by Part D plans since 2006. It examines the latest information and trends related to Part D enrollment and plan availability, premiums, benefit design and cost sharing, pharmacy networks, the Low-Income Subsidy Program, and plan performance ratings.
-
10 Things to Know About Medicare Part D Coverage and Costs in 2019
Issue BriefThe Medicare Part D program provides an outpatient prescription drug benefit to older adults and people with long-term disabilities in Medicare who enroll in private plans. This analysis provides the latest data about Medicare Part D coverage and costs in 2019 and trends over time, including enrollment, premiums, cost sharing, and participation in the low-income subsidy program.
-
How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
Issue BriefPrescription drug costs are a pressing concern for both consumers and policymakers. This analysis compares prescription drug spending and use in large private employer plans, Medicare Part D, and Medicaid, based primarily on claims data by payer, which does not account for rebates.
-
KFF COVID-19 Vaccine Monitor: The Pandemic’s Toll on Workers and Family Finances During the Omicron Surge
Poll FindingThe Vaccine Monitor report examines how families and workers fared financially during the omicron surge. Large shares of workers missed work due to being sick from coronavirus, having to quarantine, or their workplace being closed due to the pandemic. Many, particularly those with lower incomes, report impacts on their family’s finances and stress level.
-
Do State Decisions to Prioritize Renewals for Medicaid Enrollees Who are Likely Ineligible Affect Early Disenrollment Rates?
Policy WatchSome states are prioritizing Medicaid renewals for enrollees flagged as likely to be ineligible. Early data from Arizona, Idaho, and Pennsylvania show disenrollment rates for flagged enrollees are higher than for other enrollees. This analysis considers why different state approaches to renewals may explain some – but not all – variation in disenrollment rates across the U.S.
-
Understanding the Inequitable Impacts of Hurricanes and Other Natural Disasters in the Wake of Hurricanes Helene and Milton
Policy WatchThe Southeast region of the U.S. is particularly vulnerable to severe tropical storms due to climate change, and its persistently high poverty rates inhibit residents’ ability to prepare for and recover from storms. Many of the states in the Southeast have not implemented the ACA Medicaid expansion, leaving lower income residents with more limited access to health care, which may lead to challenges addressing their health needs.
-
A Current Snapshot of the Medicare Part D Prescription Drug Benefit
Issue BriefThis brief provides an overview of the Medicare Part D prescription drug benefit, including current data on plan availability, enrollment, and spending and financing, and highlights changes made under the Inflation Reduction Act.